Bioventus Inc (BVS)
5.46
-0.12
(-2.15%)
USD |
NASDAQ |
Jun 25, 16:00
5.46
0.00 (0.00%)
After-Hours: 20:00
Bioventus Revenue (Quarterly): 129.46M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 129.46M |
| December 31, 2023 | 135.42M |
| September 30, 2023 | 120.79M |
| June 30, 2023 | 137.07M |
| March 31, 2023 | 119.06M |
| December 31, 2022 | 125.83M |
| September 30, 2022 | 128.66M |
| June 30, 2022 | 140.33M |
| March 31, 2022 | 117.29M |
| December 31, 2021 | 130.41M |
| Date | Value |
|---|---|
| September 30, 2021 | 108.89M |
| June 30, 2021 | 109.82M |
| March 31, 2021 | 81.78M |
| December 31, 2020 | 98.59M |
| September 30, 2020 | 85.91M |
| June 30, 2020 | 58.02M |
| March 31, 2020 | 78.64M |
| December 31, 2019 | 97.55M |
| March 31, 2016 | 65.40M |
| March 31, 2015 | 53.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
58.02M
Minimum
Jun 2020
140.33M
Maximum
Jun 2022
111.31M
Average
118.17M
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 7.599M |
| Xtant Medical Holdings Inc | 27.87M |
| Asensus Surgical Inc | 1.123M |
| Catheter Precision Inc | 0.082M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.57M |
| Total Expenses (Quarterly) | 123.84M |
| EPS Diluted (Quarterly) | -0.07 |
| Enterprise Value | 762.00M |
| Gross Profit Margin (Quarterly) | 68.27% |
| Profit Margin (Quarterly) | -3.53% |
| Earnings Yield | -6.20% |
| Operating Earnings Yield | 5.94% |
| Normalized Earnings Yield | -4.929 |